Evidence map›Paper›PMID 37076975›Full record

ArticleCNS neuroscience & therapeutics2023

Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats.

Abdalla M Albeely, Caitlin J Nolan, Duncan J Rasmussen, Craig D C Bailey, Melissa L Perreault

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Transcriptomic Analysis of the Human Habenula in Schizophrenia.The American journal of psychiatry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdalla M AlbeelyDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0002-4901-9103
Caitlin J NolanDepartment of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada.
Duncan J RasmussenDepartment of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada.
Craig D C BaileyDepartment of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0002-4320-6872
Melissa L PerreaultDepartment of Biomedical Sciences, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0002-5775-8950

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe dopamine D5 receptor (D5R) shows high expression in cortical regions, yet the role of the receptor in learning and memory remains poorly understood. This study evaluated the impact of prefrontal cortical (PFC) D5R knockdown in rats on learning and memory and assessed the role of the D5R in the regulation of neuronal oscillatory activity and glycogen synthase kinase-3 (GSK-3β), processes integral to cognitive function. MATERIALS AND

methodsUsing an adeno-associated viral (AAV) vector, male rats were infused with shRNA to the D5R bilaterally into the PFC. Local field potential recordings were taken from freely moving animals and spectral power and coherence were evaluated in, and between, the PFC, orbitofrontal cortex (OFC), hippocampus (HIP), and thalamus. Animals were then assessed in object recognition, object location, and object in place tasks. The activity of PFC GSK-3β, a downstream effector of the D5R, was evaluated.

resultsAAV-mediated knockdown of the D5R in the PFC induced learning and memory deficits. These changes were accompanied by elevations in PFC, OFC, and HIP theta spectral power and PFC-OFC coherence, reduced PFC-thalamus gamma coherence, and increased PFC GSK-3β activity.

conclusionThis work demonstrates a role for PFC D5Rs in the regulation of neuronal oscillatory activity and learning and memory. As elevated GSK-3β activity has been implicated in numerous disorders of cognitive dysfunction, this work also highlights the potential of the D5R as a novel therapeutic target via suppression of GSK-3β.

Indexed as

NeuronsReceptors, Dopamine D5AnimalsGlycogen Synthase Kinase 3 betaHippocampusMalePrefrontal CortexRatsReceptors, Dopamine D1Glycogen Synthase Kinase 3 betaReceptors, Dopamine D1Receptors, Dopamine D5Dopamine D5 receptorneuronal oscillationsprefrontal cortexrecognition memoryspatial memory

Identifiers

PMID37076975
PMCPMC10401150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.